Literature DB >> 9466761

Hepatitis G virus infection in Amerindians and other Venezuelan high-risk groups.

F H Pujol1, Y E Khudyakov, M Devesa, M E Cong, C L Loureiro, L Blitz, F Capriles, S Beker, F Liprandi, H A Fields.   

Abstract

Recently, a new virus related to flaviviruses, the hepatitis G virus (HGV), or GBV-C virus, was discovered as a putative blood-borne human pathogen. HGV RNA (NS5 region) was amplified by reverse transcription-nested PCR in the sera of 6 of 64 (9%) hemodialysis patients; 2 of 80 (2.5%) West Yukpa Amerindians, a population with a high rate of HBV infection but negative for HCV infection; and 1 patient with an acute episode of non-A, non-B, non-C hepatitis (NABCH). The patterns of single-strand conformation polymorphism of the amplified products were unique among different specimens and similar on follow-up for hemodialysis patients. All patients tested remained HGV RNA positive 1 and 2 years later, without major sequence variation, except for the NABCH patient, for whom a double infection and an apparent clearance of the original dominant variant was observed after 2 years. The sequences of the NS5 amplified products demonstrated 85 to 90% identity with other reported HGV sequences.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466761      PMCID: PMC104562     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors.

Authors:  T Laskus; L F Wang; J Rakela; H Vargas; A D Pinna; A C Tsamandas; A J Demetris; J Fung
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

2.  The cloning and clinical implications of HGV and HGBV-C.

Authors:  H J Alter
Journal:  N Engl J Med       Date:  1996-06-06       Impact factor: 91.245

3.  The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides.

Authors:  P A Offit; H F Clark; W G Stroop; E M Twist; S A Plotkin
Journal:  J Virol Methods       Date:  1983-07       Impact factor: 2.014

4.  Sequence variation within a nonstructural region of the hepatitis G virus genome.

Authors:  Y E Khudyakov; M E Cong; M T Bonafonte; S Abdulmalek; B L Nichols; S Lambert; M J Alter; H A Fields
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology.

Authors:  M Yoshiba; H Okamoto; S Mishiro
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

6.  Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.

Authors:  M Kurosaki; N Enomoto; F Marumo; C Sato
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

7.  High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence.

Authors:  F H Pujol; J G Ponce; M G Lema; F Capriles; M Devesa; F Sirit; M Salazar; G Vásquez; F Monsalve; L Blitz-Dorfman
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

9.  Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.

Authors:  J Linnen; J Wages; Z Y Zhang-Keck; K E Fry; K Z Krawczynski; H Alter; E Koonin; M Gallagher; M Alter; S Hadziyannis; P Karayiannis; K Fung; Y Nakatsuji; J W Shih; L Young; M Piatak; C Hoover; J Fernandez; S Chen; J C Zou; T Morris; K C Hyams; S Ismay; J D Lifson; G Hess; S K Foung; H Thomas; D Bradley; H Margolis; J P Kim
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

10.  Infection with hepatitis GB virus C in patients on maintenance hemodialysis.

Authors:  K Masuko; T Mitsui; K Iwano; C Yamazaki; K Okuda; T Meguro; N Murayama; T Inoue; F Tsuda; H Okamoto; Y Miyakawa; M Mayumi
Journal:  N Engl J Med       Date:  1996-06-06       Impact factor: 91.245

View more
  1 in total

Review 1.  Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?

Authors:  Jack T Stapleton
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.